Fiduciary Trust’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$828K Sell
2,140
-89
-4% -$33K 0.01% 460
2026
Q1
$653K Sell
2,229
-66
-3% -$21.7K 0.01% 509
2025
Q4
$804K Sell
2,295
-126
-5% -$42.6K 0.01% 462
2025
Q3
$782K Buy
2,421
+63
+3% +$19.6K 0.01% 468
2025
Q2
$917K Buy
2,358
+262
+13% +$105K 0.01% 416
2025
Q1
$912K Sell
2,096
-25
-1% -$10K 0.01% 404
2024
Q4
$782K Sell
2,121
-534
-20% -$223K 0.01% 404
2024
Q3
$1.38M Buy
2,655
+586
+28% +$313K 0.02% 310
2024
Q2
$1.12M Buy
2,069
+3
+0.1% +$1.59K 0.02% 323
2024
Q1
$1.07M Buy
2,066
+7
+0.3% +$3.48K 0.02% 337
2023
Q4
$971K Buy
2,059
+190
+10% +$87.9K 0.02% 342
2023
Q3
$814K Sell
1,869
-164
-8% -$74.4K 0.01% 346
2023
Q2
$903K Sell
2,033
-51
-2% -$23.5K 0.02% 347
2023
Q1
$958K Buy
2,084
+84
+4% +$40K 0.02% 335
2022
Q4
$1.03M Buy
2,000
+151
+8% +$76.7K 0.02% 334
2022
Q3
$840K Buy
1,849
+17
+0.9% +$8.13K 0.02% 349
2022
Q2
$885K Sell
1,832
-45
-2% -$22.3K 0.02% 346
2022
Q1
$922K Buy
1,877
+488
+35% +$223K 0.02% 360
2021
Q4
$644K Sell
1,389
-2
-0.1% -$841 0.01% 430
2021
Q3
$519K Sell
1,391
-13
-0.9% -$4.94K 0.01% 471
2021
Q2
$536K Buy
1,404
+35
+3% +$13.4K 0.01% 453
2021
Q1
$492K Sell
1,369
-660
-33% -$212K 0.01% 454
2020
Q4
$652K Sell
2,029
-255
-11% -$78.3K 0.01% 385
2020
Q3
$613K Buy
2,284
+500
+28% +$135K 0.01% 365
2020
Q2
$469K Sell
1,784
-4
-0.2% -$1.07K 0.01% 391
2020
Q1
$406K Sell
1,788
-1,501
-46% -$409K 0.01% 374
2019
Q4
$993K Buy
3,289
+1,289
+64% +$355K 0.02% 280
2019
Q3
$480K Buy
2,000
+82
+4% +$22.5K 0.01% 379
2019
Q2
$542K Buy
1,918
+225
+13% +$61.5K 0.01% 346
2019
Q1
$486K Hold
1,693
0.01% 353
2018
Q4
$445K Hold
1,693
0.01% 338
2018
Q3
$464K Sell
1,693
-58
-3% -$15.1K 0.01% 345
2018
Q2
$416K Sell
1,751
-162
-8% -$37.5K 0.01% 346
2018
Q1
$420K Sell
1,913
-49
-2% -$11.5K 0.01% 343
2017
Q4
$441K Sell
1,962
-100
-5% -$21.3K 0.01% 330
2017
Q3
$391K Sell
2,062
-67
-3% -$12.8K 0.01% 342
2017
Q2
$400K Sell
2,129
-1,596
-43% -$287K 0.01% 342
2017
Q1
$616K Hold
3,725
0.02% 307
2016
Q4
$536K Sell
3,725
-377
-9% -$50.5K 0.02% 321
2016
Q3
$514K Sell
4,102
-2,413
-37% -$312K 0.02% 327
2016
Q2
$856K Sell
6,515
-94
-1% -$12.9K 0.03% 279
2016
Q1
$919K Buy
6,609
+416
+7% +$55.6K 0.03% 268
2015
Q4
$863K Buy
6,193
+2,919
+89% +$402K 0.04% 248
2015
Q3
$458K Buy
3,274
+1,850
+130% +$278K 0.02% 287
2015
Q2
$233K Hold
1,424
0.01% 325
2015
Q1
$220K Buy
+1,424
New +$203K 0.01% 327

Other funds holding ELV

Fiduciary Trust's ELV Position: Q2 2026 in Review

Fiduciary Trust reduced its Elevance Health (ELV) stake by 4% in Q2 2026, selling an estimated $33K and leaving 2,140 shares worth $828K. The position accounts for 0.01% of the portfolio, ranked #460.

Fiduciary Trust first reported a position in ELV in Q1 2015 and has held it in 46 quarters since. The position peaked at $1.38M in Q3 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Fiduciary Trust held 2,140 shares of Elevance Health worth $828K as of Q2 2026.
  • Fiduciary Trust sold 89 Elevance Health shares in Q2 2026, an estimated $33K.
  • Elevance Health made up 0.01% of Fiduciary Trust's portfolio in Q2 2026, its #460 holding.
  • Fiduciary Trust first reported a position in Elevance Health in Q1 2015 and has held it in 46 quarters since.
  • Fiduciary Trust's Elevance Health position peaked at $1.38M in Q3 2024.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.